EA201291042A1 - Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида - Google Patents

Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида

Info

Publication number
EA201291042A1
EA201291042A1 EA201291042A EA201291042A EA201291042A1 EA 201291042 A1 EA201291042 A1 EA 201291042A1 EA 201291042 A EA201291042 A EA 201291042A EA 201291042 A EA201291042 A EA 201291042A EA 201291042 A1 EA201291042 A1 EA 201291042A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nucleoside
combination
uclus
macrocyclic
macrocyclic inhibitor
Prior art date
Application number
EA201291042A
Other languages
English (en)
Inventor
Цзе-И Линь
Оливер Ленц
Пьер Жан-Мари Бернар Рабуассон
Original Assignee
Янссен Фармасьютикалз, Инк.
Медивир Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармасьютикалз, Инк., Медивир Аб filed Critical Янссен Фармасьютикалз, Инк.
Publication of EA201291042A1 publication Critical patent/EA201291042A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Настоящее изобретение относится к комбинации макроциклического ингибитора протеазы HCV, макроциклического ненуклеозидного ингибитора полимеразы HCV и нуклеозидного ингибитора полимеразы HCV.
EA201291042A 2010-04-13 2011-04-13 Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида EA201291042A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10159825 2010-04-13
PCT/EP2011/055836 WO2011128378A1 (en) 2010-04-13 2011-04-13 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside

Publications (1)

Publication Number Publication Date
EA201291042A1 true EA201291042A1 (ru) 2013-03-29

Family

ID=42237337

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291042A EA201291042A1 (ru) 2010-04-13 2011-04-13 Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида

Country Status (14)

Country Link
US (1) US20130028865A1 (ru)
EP (1) EP2558091A1 (ru)
JP (1) JP5989635B2 (ru)
KR (1) KR20130057990A (ru)
CN (1) CN102844028B (ru)
AU (1) AU2011239974B2 (ru)
BR (1) BR112012026016A2 (ru)
CA (1) CA2796243A1 (ru)
EA (1) EA201291042A1 (ru)
HK (1) HK1180222A1 (ru)
MX (1) MX2012011963A (ru)
NZ (1) NZ602552A (ru)
SG (2) SG184524A1 (ru)
WO (1) WO2011128378A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
TWI454476B (zh) 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
US20150209366A1 (en) * 2012-08-31 2015-07-30 Janssen Pharmaceuticals, Inc. Combination of a macrocyclic protease inhibitor of hcv, a non-nucleoside hcv inhibitor and ritonavir

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1713823T3 (pl) 2004-01-30 2010-04-30 Medivir Ab Inhibitory proteazy serynowej NS-3 HCV
PE20070211A1 (es) * 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
WO2008043704A1 (en) 2006-10-10 2008-04-17 Medivir Ab Hcv nucleoside inhibitor
TWI454476B (zh) 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
AR073603A1 (es) * 2008-09-18 2010-11-17 Ortho Mcneil Janssen Pharm Combinaciones sinergicas de un inhibidor macrociclico del vhc y un nucleosido
AR077125A1 (es) * 2009-06-23 2011-08-03 Gilead Sciences Inc Combinaciones farmaceuticas utiles para tratar el vhc

Also Published As

Publication number Publication date
US20130028865A1 (en) 2013-01-31
EP2558091A1 (en) 2013-02-20
AU2011239974A1 (en) 2012-10-25
CN102844028B (zh) 2016-04-06
SG184524A1 (en) 2012-11-29
JP5989635B2 (ja) 2016-09-07
NZ602552A (en) 2014-09-26
WO2011128378A1 (en) 2011-10-20
KR20130057990A (ko) 2013-06-03
BR112012026016A2 (pt) 2016-06-07
MX2012011963A (es) 2012-12-17
CN102844028A (zh) 2012-12-26
CA2796243A1 (en) 2011-10-20
AU2011239974B2 (en) 2015-12-03
JP2013523866A (ja) 2013-06-17
SG10201506652QA (en) 2015-10-29
HK1180222A1 (zh) 2013-10-18

Similar Documents

Publication Publication Date Title
CY2017033I2 (el) Αναστολεις πρωτεασης σερινης hcv λαμβανομενοι απο μακροκυκλικη προλινη
EA201590534A1 (ru) Новые бициклические производные
EA201101620A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
UA107822C2 (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
MX2020001159A (es) Composiciones y metodos que comprenden una variante de enzima lipolitica.
EA201270423A1 (ru) Ингибиторы протеазы hcv
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
EA201270149A1 (ru) Ингибиторы bace
IN2014DN09346A (ru)
TR201901382T4 (tr) Serin proteaz varyantlarını içeren bileşimler ve yöntemler.
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
MX356282B (es) Composiciones y metodos que comprenden variantes de proteasa.
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
ITRM20100277A1 (it) Carcassa di turbina.
EP2632908A4 (en) SULFONAMIDE AS AN HIV PROTEASE INHIBITOR
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
TR201905787T4 (tr) Liyofilize TAT-NR2B9C formülasyonu.
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
BR112013015996A2 (pt) enzimas c. bescii termoestáveis
HK1204433A1 (en) Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith hcv ns5a
UY34465A (es) ?inhibidor de alfa1-proteinasa para demorar el comienzo o progresión de exacerbaciones pulmonares?.
ITTO20110268A1 (it) Composizione di maquillage.
EA201291042A1 (ru) Комбинация макроциклического ингибитора hcv, ненуклеозида и нуклеозида
UA111663C2 (uk) Газопродувний елемент і співвіднесений газопідвідний трубопровід
UY34099A (es) ?composición de agentes de coalescencia?.